Eam Global Investors LLC Axsome Therapeutics, Inc. Transaction History

Eam Global Investors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $676,184 - $1.35 Million	-16,930 Reduced 44.3%	21,288 $1.64 Million
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $830,859 - $1.79 Million	38,218 New	38,218 $1.46 Million
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $1.27 Million - $1.59 Million	-18,569 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$49.87 - $98.69 $1.6 Million - $3.17 Million	-32,080 Reduced 63.34%	18,569 $1.53 Million
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $430,251 - $1.06 Million	10,443 Added 25.97%	50,649 $2.98 Million
Q4 2019 Feb 10, 2020	SELL	$16.71 - $106.24 $307,731 - $1.96 Million	-18,416 Reduced 31.41%	40,206 $4.16 Million
Q3 2019 Nov 13, 2019	SELL	$20.24 - $29.16 $15,746 - $22,686	-778 Reduced 1.31%	58,622 $1.19 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $345,733 - $661,414	-25,686 Reduced 30.19%	59,400 $1.53 Million
Q1 2019 May 10, 2019	BUY	$2.63 - $16.34 $223,776 - $1.39 Million	85,086 New	85,086 $1.21 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.